Lasa Supergenerics Limited
LASA.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$273.9M
Close$
Share Statistics
| Market cap | $273.90 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $-6.8 |
| Beta | 0.64 |
| Outstanding Shares | 50,101,200 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -1.61 |
|---|---|
| PEG | 1.94 |
| Price to Sales | 5.39 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Lasa Supergenerics Limited
9 employees
CEO: Omkar Pravin Herlekar Lasa Supergenerics Limited is an Indian-based company that specializes in the research, development, production, and commercialization of healthcare products for both animals and humans, primarily serving the domestic market in India. It...